RIMACTANE KAPSUL 300 MG

Negara: Indonesia

Bahasa: Bahasa Indonesia

Sumber: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Karakteristik produk Karakteristik produk (SPC)
01-01-2015

Bahan aktif:

RIFAMPICIN

Tersedia dari:

SANDOZ INDONESIA - Indonesia

INN (Nama Internasional):

RIFAMPICIN

Dosis:

300 MG

Bentuk farmasi:

KAPSUL

Unit dalam paket:

DUS, 5 BLISTER @ 10 KAPSUL

Diproduksi oleh:

NOVARTIS INDONESIA - Indonesia

Tanggal Otorisasi:

2015-11-30

Karakteristik produk

                                RIMACTANE
0
Rifompicin
f'J
SANDOZ
Composition
Eoch Rimoctane· 300 mg Copsule contains rifompicin 300 mg.
Eoch Rimactane' 450 mg Sugar-cooled coptob conic.ins rifompicin 450
mg.
Eoch Rimoclane' 600 mg Sugar-cooled copt'.lb contains rifampicin 600
mg.
Each
_5 _
ml Rimoctone· Syrup contains ri:ompicin
l
00 mg.
Theropeutic Indications
•
Mycobocleriol Infections Tuberculc.sis (all forms)
Rir,1oclone· must always be combined with at least one other
ontituberculos
i
s agents.
•
leprosy
In combination with dopsone ono
clofo�imine as
treatment
for multibocillcry
form� of
leprosy [Lepromotous (LL], Borderline lepromotous {SL), Borderline
{BB]].
In
comb:notion
with
dopsone
as
treatment
for
priucibocillcry
forms
of
leprosy
[T
uberculoid (TTI. Borderline Tuberculoid (BTl].
Phosology and Method of Administration
1
_Myco_
_b_
_cclericl _
_l_
_nfec/ions Tu_
_b_
_�rcu_
_l_
_osis {all lormsj _
_I _
!t)
t�
f��{!.-.. � __
1
tdult
•
P,
JJ.nMh1.J�
t
- Adults weighing less than 50 k�: J50 mg Rimocton� ij
'
y
t; ____ .. ____ _
-
.
Adults weighir.g _50 _kg or r,1ore: 6�0 ms Rimocione
J
o
· tr,U[J.J:/.:'li ___
..
___
----1
S::nilqren:
10 - 20 mg/kg Rimocton� doily.
l __
, __ _
Maximum
permissible
doily
dose:
600 mg
doily.
The
chemotheropou�c
agents usually
employed today os
combined therapy for tuberculosis ore rifompicin
(RMP, Rimoctcne°).
isoniozide (1Nl:IJ, pyro2incmide {PZAj, ethcmbutol {ElvlB),
stre;:,tornych (!>TM). The dosage
as recomme�ded by WHO ore cs follows:
Drug
RMP
tNH
PZA
EMB
STM
_____
Ocilv
m
o
/
ka
MOX.MCI
10
600
8
<100
30
2000
20
l
1200
.J..5
______ IJ.QO.Q_ _
-
'
2OR3TIMESCW�
mo/ka
Mox. mo
10
600
15
_750 _
50
35CO
_
4C
2000
15
-
- _j 1000
·-·
For the treo:ment of sputum-positive pulmo;,ory tuberculosis,
preferenc& is nowadays given to
the following regiment.;:
_Conlinuous Therapy _
_/7 _
_limes c wee<} _
Tote! duration 9 moPths:
-
,nitiol phose fer 2 mo�th!: RMP + ll�H
T
EMB or STM
- continuation phase for 7 monlhi: RMP + !NH.
The short tenms ontituberculosis drug for adult
                                
                                Baca dokumen lengkapnya
                                
                            

Peringatan pencarian terkait dengan produk ini